Literature DB >> 7033141

In vivo changes in complement induced with peptidoglycan-polysaccharide polymers from streptococcal cell walls.

J D Lambris, J B Allen, J H Schwab.   

Abstract

In rats injected with an arthropathogenic dose of streptococcal cell wall fragments, serum hemolytic activity decreased over the first 24 h and was then elevated from days 2 through 6 after injection. Hemolytic activity was again elevated at days 16 and 40. Levels of activity of alternative complement pathway, C3, and factor D were also altered.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7033141      PMCID： PMC351043          DOI： 10.1128/iai.35.1.377-380.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  21 in total

1.  Human factor D of the alternative complement pathway: purification and characterization.

Authors:  J E Volanakis; R E Schrohenloher; R M Stroud
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

2.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

3.  Activation of the alternate complement pathway by peptidoglycan from streptococcal cell wall.

Authors:  J Greenblatt; R J Boackle; J H Schwab
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

4.  The interactions of human complement with interfacially aggregated preparations of human secretory IgA.

Authors:  R J Boackle; K M Pruitt; J Mestecky
Journal:  Immunochemistry       Date:  1974-09

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Level of complement activity and components C1, C4, C2, and C3 in complement response to bacterial challenge in malnourished rats.

Authors:  M Sakamoto; S Ishii; K Nishioka; K Shimada
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

7.  Role of complement in the expression of delayed-type hypersensitivity in rats: studies with cobra venom factor.

Authors:  T W Jungi; D D McGregor
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Interaction of lipopolysaccharides and lipid A with complement in rats and its relation to endotoxicity.

Authors:  M A Freudenberg; C Galanos
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

9.  Cytotoxicity of rat macrophages activated by persistent or biodegradable bacterial cell walls.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

10.  Processing of streptococcal cell walls by rat macrophages and human monocytes in vitro.

Authors:  R J Smialowicz; J H Schwab
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441
View more
  10 in total

1.  Arthropathic group A streptococcal cell walls require specific antibody for activation of human complement by both the classical and alternative pathways.

Authors:  R A Eisenberg; J H Schwab
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

3.  Stimulation of complement component C3 synthesis in macrophagelike cell lines by group B streptococci.

Authors:  K J Goodrum
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

4.  Opsonized streptococcal cell walls cross-link human leukocytes and erythrocytes by complement receptors.

Authors:  K B Pryzwansky; J D Lambris; E K MacRae; J H Schwab
Journal:  Infect Immun       Date:  1985-09       Impact factor: 3.441

5.  A monoclonal antibody to high-molecular weight kininogen is therapeutic in a rodent model of reactive arthritis.

Authors:  Ricardo G Espinola; Audrey Uknis; Irma M Sainz; Irma Isordia-Salas; Robin Pixley; Raul DeLa Cadena; Walter Long; Alexis Agelan; John Gaughan; Albert Adam; Robert W Colman
Journal:  Am J Pathol       Date:  2004-09       Impact factor: 4.307

6.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

7.  In vivo degradation of bacterial cell wall by the muralytic enzyme mutanolysin.

Authors:  M J Janusz; R E Esser; J H Schwab
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

8.  Antibody to streptococcal cell wall peptidoglycan-polysaccharide polymers in seropositive and seronegative rheumatic disease.

Authors:  P M Johnson; K K Phua; H R Perkins; C A Hart; R C Bucknall
Journal:  Clin Exp Immunol       Date:  1984-01       Impact factor: 4.330

9.  Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats.

Authors:  J B Allen; D G Malone; S M Wahl; G B Calandra; R L Wilder
Journal:  J Clin Invest       Date:  1985-09       Impact factor: 14.808

10.  Localized gut-associated lymphoid tissue hemorrhage induced by intravenous peptidoglycan-polysaccharide polymers.

Authors:  R B Sartor; S K Anderle; W J Cromartie; J H Schwab
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.